These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7826070

  • 1. [Treatment of recurrent uterine endometrial cancer in adjuvant therapy with medroxyprogesterone acetate (MPA) in addition of etoposide].
    Ishizaki T, Yamamoto T, Itoh R, Yasuda J, Fujita H, Okada H.
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):137-40. PubMed ID: 7826070
    [Abstract] [Full Text] [Related]

  • 2. [A case of recurrent endometrial cancer successfully treated with oral administration of etoposide].
    Tsuruchi N, Jimi S.
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):103-5. PubMed ID: 1729957
    [Abstract] [Full Text] [Related]

  • 3. [Hormonal therapy for endometrial adenocarcinoma].
    Susumu N, Aoki D, Suzuki N, Nozawa S.
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A case of recurrent uterine cervical cancer successfully treated with etoposide].
    Kobayashi H, Kawashima Y.
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3279-82. PubMed ID: 2782919
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A case of recurrent ovarian cancer successfully treated with etoposide].
    Wakisaka T, Sou S.
    Gan To Kagaku Ryoho; 1988 May; 15(5):1795-8. PubMed ID: 3369875
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
    Pierga JY, Dieras V, Paraiso D, Dorval T, Palangie T, Beuzeboc P, Jouve M, Scholl SM, Garcia-Giralt E, Pouillart P.
    Gynecol Oncol; 1996 Jan; 60(1):59-63. PubMed ID: 8557229
    [Abstract] [Full Text] [Related]

  • 13. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG, Blessing JA, Van Le L, Waggoner S.
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH, Boyd ME, Colgan TJ, Ferenczy A, Fugere P, Lorrain J.
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [Abstract] [Full Text] [Related]

  • 16. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
    Niwa K, Tagami K, Lian Z, Onogi K, Mori H, Tamaya T.
    BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
    Tajima H, Okada T, Fujimori Y, Tomioka Y, Hirano M, Yoshida T, Ikeda S, Hata T.
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.